Release Date: 06/01/09 17:12 Summary: Pre-quotation disclosure Price Sensitive: Yes Download Document 139.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%